ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Panacea Biotec Ltd

NSE: PANACEABIO · BSE: 531349 · Pharmaceuticals & Biotechnology · 31 announcements

Share price
₹353.70
Market cap
₹2,166 Cr
Revenue (annual)
₹639.8 Cr
Net profit (annual)
₹-5.38 Cr
P/E (TTM)
-304.3×Sector 43.8×
Promoter holding
72.48%+0.00% QoQ
FII holding
2.75%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:22 IST NSE
New Order Win

Panacea Biotec Bags ₹120.9 Cr Order

Panacea Biotec joined the €11.1 million (₹120.90 Crore) EU-funded DENSTAR consortium. The 48-month project advances licensure of its DengiAll vaccine in sub-Saharan Africa.

Value
₹120.9 Cr
Execution
48 months
16:01 IST BSE
New Order Win

Panacea Biotec Bags ₹20.79 Cr Order

Panacea Biotec Ltd secured a ₹20.79 Crore contract from the Central Medical Services Society (CMSS) to supply Diphtheria and Tetanus Vaccine (Td Vaccine). Deliveries will occur in several tranches between late 2026 and late 2028, providing steady revenue visibility for the company's vaccine segment.

Value
₹20.79 Cr
Execution
September / October 2026 till November / December 2028